Literature DB >> 6746579

Thyroid hormone and the TRH stimulation test in refractory depression.

S D Targum, R D Greenberg, R L Harmon, K Kessler, A J Salerian, D H Fram.   

Abstract

Seven of 21 refractory depressed patients responded within 7 days to combined thyroid hormone-antidepressant treatment. Five of the 7 responders revealed evidence of subclinical hypothyroidism, suggesting that this subpopulation of depressed patients may benefit most from adjunctive thyroid hormone.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6746579

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  3 in total

Review 1.  Risk of adverse events with the use of augmentation therapy for the treatment of resistant depression.

Authors:  I Schweitzer; V Tuckwell
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

2.  Subclinical hypothyroidism resulting from autoimmune thyroiditis in female patients with endogenous depression.

Authors:  N Custro; V Scafidi; R Lo Baido; L Nastri; G Abbate; M P Cuffaro; S Gallo; G Vienna; A Notarbartolo
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

3.  Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?

Authors:  Jing Yu; Ai-Juan Tian; Xin Yuan; Xiao-Xin Cheng
Journal:  PLoS One       Date:  2016-05-02       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.